B.1.617.2 enters and fuses lung cells with increased efficiency
Por um escritor misterioso
Descrição
The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), B.1.617.2, emerged in India and has spread to over 80 countries. B.…
Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses - eBioMedicine
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity
PDF) Increased lung cell entry of B.1.617.2 and evasion of antibodies induced by infection and BNT162b2 vaccination
Dissecting the Unusual Biology of the SARS-CoV-2 Delta Variant
Omicron subvariant BA.5 efficiently infects lung cells
Deutsches Primatenzentrum: Delta and Delta Plus evade the antibody response
Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant
Messages from the COVID-19 Response Task Force
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination - ScienceDirect
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies - ScienceDirect
A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection
Omicron subvariant BA.5 efficiently infects lung cells
Delta variant exhibits immune evasion, enhanced cell entry, and augmented syncytium formation
Full article: SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells
